- Home
- NBIX vs MTZ Comparison
NBIX vs MTZ Comparison
Compare NBIX & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- MTZ
- Stock Information
- Founded
- NBIX 1992
- MTZ 1929
- Country
- NBIX United States
- MTZ United States
- Employees
- NBIX N/A
- MTZ N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- MTZ Water Sewer Pipeline Comm & Power Line Construction
- Sector
- NBIX Health Care
- MTZ Industrials
- Exchange
- NBIX Nasdaq
- MTZ Nasdaq
- Market Cap
- NBIX 14.4B
- MTZ 13.6B
- IPO Year
- NBIX 1996
- MTZ N/A
- Fundamental
- Price
- NBIX $140.02
- MTZ $202.23
- Analyst Decision
- NBIX Strong Buy
- MTZ Strong Buy
- Analyst Count
- NBIX 17
- MTZ 21
- Target Price
- NBIX $164.94
- MTZ $214.75
- AVG Volume (30 Days)
- NBIX 803.5K
- MTZ 894.1K
- Earning Date
- NBIX 10-28-2025
- MTZ 10-30-2025
- Dividend Yield
- NBIX N/A
- MTZ N/A
- EPS Growth
- NBIX 2.97
- MTZ 3211.19
- EPS
- NBIX 3.39
- MTZ 3.34
- Revenue
- NBIX $2,509,900,000.00
- MTZ $13,047,952,000.00
- Revenue This Year
- NBIX $20.79
- MTZ $14.77
- Revenue Next Year
- NBIX $14.73
- MTZ $9.26
- P/E Ratio
- NBIX $40.99
- MTZ $60.42
- Revenue Growth
- NBIX 18.42
- MTZ 7.08
- 52 Week Low
- NBIX $84.23
- MTZ $99.70
- 52 Week High
- NBIX $154.61
- MTZ $221.83
- Technical
- Relative Strength Index (RSI)
- NBIX 53.84
- MTZ 49.29
- Support Level
- NBIX $136.71
- MTZ $196.65
- Resistance Level
- NBIX $140.73
- MTZ $209.02
- Average True Range (ATR)
- NBIX 3.35
- MTZ 8.26
- MACD
- NBIX -0.34
- MTZ -2.15
- Stochastic Oscillator
- NBIX 72.66
- MTZ 23.17
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. The company's primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.